Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin effects in metabolic syndrome
NCT00138528Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluvastatin in metabolic syndrome, sponsored by Novartis. Started Oct 2004; status: completed.
02
Drugs
fluvastatin
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00138528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138528.